# A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

> **NCT04840680** · — · COMPLETED · sponsor: **Takeda** · enrollment: 191 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT04840680
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2023-07-06
- **Final completion:** 2023-08-28
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04840680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04840680, "A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04840680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*